This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boyne, M. S. Articles by Forrester, T. E. Search for Related Content PubMed PubMed Citation Articles by Boyne, M. S. Articles by Forrester, T. E.

The Relationship among Circulating Insulin-Like Growth Factor (IGF)-I, IGF-Binding Proteins-1 and -2, and Birth Anthropometry: A Prospective Study

Tropical Metabolism Research Unit (M.S.B., M.T., F.I.B., T.E.F.), Tropical Medicine Research Institute, The University of the West Indies, Mona, Kingston 7, Jamaica; Medical Research Council Environmental Epidemiology Unit (C.O.), University of Southampton, Southampton General Hospital, Southampton, United Kingdom SO16 6YD; and Department of Medicine (J.P.M.), King’s College School of Medicine and Dentistry, London, United Kingdom SE5 9PJ

Address all correspondence and requests for reprints to: Prof. Terrence E. Forrester, Tropical Metabolism Research Unit, Tropical Medicine Research Institute, The University of the West Indies, Mona, Kingston 7, Jamaica. E-mail: tesgf{at}mail.infochan.com.

Fetal IGF-I is a determinant of birth weight, but whether maternal IGF-I plays a significant role is controversial. We sought to examine the relationships among maternal IGF-I, IGF-binding protein (IGFBP)-1, and IGFBP-2, with maternal and newborn anthropometry, in a cohort of 325 nondiabetic pregnant women of African origin. Blood was collected for IGF-I, IGFBP-1, and IGFBP-2 at 9, 25, and 35 wk gestation and in cord blood at delivery.

In the second and third trimesters, maternal IGF-I was significantly correlated (P < 0.005) with maternal body mass index and triceps skinfold thickness. Maternal IGFBP-1 and -2 had an inverse correlation (P < 0.0001), with maternal anthropometry. Maternal IGF-I at 35 wk, and fetal IGF-I by cord blood were significantly correlated with birth weight (P = 0.001 and 0.048, respectively). IGFBP-1 in the third trimester and cord blood were negatively correlated with birth weight (P = 0.012 and 0.002). In multiple regression analyses, maternal IGF-I at 35 wk, fetal IGF-I, maternal weight at the first antenatal visit, gender, and gestational age were significant independent factors in the determination of birth weight. In conclusion, maternal IGF-I levels, especially during late pregnancy, positively influence birth weight.

Abbreviations: BMI, Body mass index; CV, coefficient(s) of variation; IGFBP, IGF-binding protein.

This article has been cited by other articles:

				E. S Schernhammer, S. S Tworoger, A H. Eliassen, S. A Missmer, J. M Holly, M. N Pollak, and S. E Hankinson Body shape throughout life and correlations with IGFs and GH Endocr. Relat. Cancer, September 1, 2007; 14(3): 721 - 732. [Abstract] [Full Text] [PDF]

				R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]

				E. Milne, C. L. Laurvick, E. Blair, C. Bower, and N. de Klerk Fetal Growth and Acute Childhood Leukemia: Looking Beyond Birth Weight Am. J. Epidemiol., July 15, 2007; 166(2): 151 - 159. [Abstract] [Full Text] [PDF]

				N. Ben Lagha, D. Seurin, Y. Le Bouc, M. Binoux, A. Berdal, P. Menuelle, and S. Babajko Insulin-Like Growth Factor Binding Protein (IGFBP-1) Involvement in Intrauterine Growth Retardation: Study on IGFBP-1 Overexpressing Transgenic Mice Endocrinology, October 1, 2006; 147(10): 4730 - 4737. [Abstract] [Full Text] [PDF]

				K. Shankar, M. Hidestrand, X. Liu, R. Xiao, C. M. Skinner, F. A. Simmen, T. M. Badger, and M. J. J. Ronis Physiologic and Genomic Analyses of Nutrition-Ethanol Interactions During Gestation: Implications for Fetal Ethanol Toxicity Experimental Biology and Medicine, September 1, 2006; 231(8): 1379 - 1397. [Abstract] [Full Text] [PDF]

				V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]

				J. A. Ross High Birthweight and Cancer: Evidence and Implications Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 1 - 2. [Full Text] [PDF]

				T. Radaelli, J. Uvena-Celebrezze, J. Minium, L. Huston-Presley, P. Catalano, and S. Hauguel-de Mouzon Maternal Interleukin-6: Marker of Fetal Growth and Adiposity Reproductive Sciences, January 1, 2006; 13(1): 53 - 57. [Abstract] [PDF]

				M. Manikkam, E. J. Crespi, D. D. Doop, C. Herkimer, J. S. Lee, S. Yu, M. B. Brown, D. L. Foster, and V. Padmanabhan Fetal Programming: Prenatal Testosterone Excess Leads to Fetal Growth Retardation and Postnatal Catch-Up Growth in Sheep Endocrinology, February 1, 2004; 145(2): 790 - 798. [Abstract] [Full Text] [PDF]